Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Propofol products are in shortage in Canada (1 of 4 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An anesthetic used to induce and maintain sleep during surgery and sedation.
Products affected
1 / 4
In shortage since
Apr 8, 2020
Reports on file
18
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-PROPOFOL
10MG · EMULSION · TEVA CANADA LIMITED
DIN 02437961 · since Jul 29, 2020, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-PROPOFOL
10MG · EMULSION · TEVA CANADA LIMITED
DIN 02437961 · since Apr 8, 2020, no end estimate · Disruption of the manufacture of the drug.
Resolved
PROPOFOL INJECTION
10MG · EMULSION · BAXTER CORPORATION
DIN 02244379 · ended Aug 23, 2024 · Delay in shipping of the drug.
Avoided
DIPRIVAN 1%
10MG · EMULSION · ASPEN PHARMACARE CANADA INC.
DIN 02018950 · ended Jul 18, 2024 · Delay in shipping of the drug.
Avoided
DIPRIVAN 1%
10MG · EMULSION · ASPEN PHARMACARE CANADA INC.
DIN 02018950 · ended Jun 25, 2024 · Demand increase for the drug.
Avoided
DIPRIVAN 1%
10MG · EMULSION · ASPEN PHARMACARE CANADA INC.
DIN 02018950 · ended May 9, 2024 · Demand increase for the drug.
Avoided
DIPRIVAN 1%
10MG · EMULSION · ASPEN PHARMACARE CANADA INC.
DIN 02018950 · ended May 9, 2024 · Demand increase for the drug.
Avoided
PROPOFOL INJECTION
10MG · EMULSION · BAXTER CORPORATION
DIN 02244379 · ended Apr 11, 2024 · Requirements related to complying with good manufacturing practices.
Avoided
PROPOFOL INJECTION
10MG · EMULSION · BAXTER CORPORATION
DIN 02244379 · ended Apr 11, 2024 · Requirements related to complying with good manufacturing practices.
Resolved
PROPOFOL INJECTION
10MG · EMULSION · BAXTER CORPORATION
DIN 02244379 · ended May 2, 2024 · Product release expected April 29, 2024
Resolved
PROPOFOL INJECTION
10MG · EMULSION · BAXTER CORPORATION
DIN 02244379 · ended Jan 10, 2024 · Requirements related to complying with good manufacturing practices.
Resolved
PMS-PROPOFOL
10MG · EMULSION · PHARMASCIENCE INC
DIN 02244379 · ended Jun 9, 2020 · Product to be discontinued.
Showing 12 of 18 reports. All reports are on file with Health Canada.
What's happening
Propofol is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Propofol is classified under “ANESTHETICS, GENERAL” (ATC N01AX).
Recent changes
No changes recorded yet.
Common questions
What is Propofol used for?
An anesthetic used to induce and maintain sleep during surgery and sedation.
When will Propofol be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Propofol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.